October 22, 2014 4:02 AM ET

Pharmaceuticals

Company Overview of Altair Therapeutics, Inc.

Company Overview

Altair Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes antisense drugs to treat asthma and other respiratory diseases. Its products include AIR645, an inhaled drug used for treatment of asthma and rhinitis. The company was founded in 2007 and is based in San Diego, California.

12555 High Bluff Drive

Suite 310

San Diego, CA 92130

United States

Founded in 2007

Phone:

858-436-3838

Fax:

415-541-8980

Key Executives for Altair Therapeutics, Inc.

Chief Executive Officer
Age: 57
Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
URL Pharma, Inc. United States
Dr. Reddy's Laboratories Inc. United States
Omega Natural Science, Inc. United States
Prismic Pharmaceuticals, Inc. United States
Transition Therapeutics (USA) Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Altair Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.